In 1970 he was appointed Professor of Biochemistry at Surrey University and a consultant chemical pathologist at the Royal Surrey County Hospital
BRP Peptide: This newly discovered brain-derived peptide suppresses feeding in GLP-1 receptor knockout mice, activates non-overlapping neurons, and does not slow gastric emptying
Discrete choice experiments can formalize the trade-offs patients and clinicians routinely makebetween expected weight loss, chances of conception, adverse effects, out-of-pocket costs, and the possibility of post-discontinuation regainso that Evidence-to-Decision processes can incorporate empirically derived weights rather than implicit assumptions
Safety risks in the GLP-1 market: an update on weight loss medication, May 2026 Drug shortages and coverage gaps have led to criminal counterfeiters exploiting Americans demand for blockbuster diabetes and weight loss drugs made with semaglutide and tirzepatide
NylanderMFrssingSKistorpCFaberJSkoubyS
GLP-1 (Glucagon-Like Peptide-1) medications are a type of prescription drug that have been gaining attention in the medical community for their potential benefits in managing various health conditions, particularly for women with Polycystic Ovary Syndrome (PCOS)